The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Pharmacological properties and derivatives of shikonin—A review in recent years
Open accessAbstract
Shikonin is the major bioactive component extracted from the roots of Lithospermum erythrorhizon which is also known as "Zicao" in Traditional Chinese Medicine (TCM). Recent studies have shown that shikonin demonstrates various bioactivities related to the treatment of cancer, inflammation, and wound healing. This review aimed to provide an updated summary of recent studies on shikonin. Firstly, many studies have demonstrated that shikonin exerts strong anticancer effects on various types of cancer by inhibiting cell proliferation and migration, inducing apoptosis, autophagy, and necroptosis. Shikonin also triggers Reactive Oxygen Species (ROS) generation, suppressing exosome release, and activate anti-tumor immunity in multiple molecular mechanisms. Examples of these effects include modulating the PI3K/AKT/mTOR and MAPKs signaling; inhibiting the activation of TrxR1, PKM2, RIP1/3, Src, and FAK; and regulating the expression of ERP57, MMPs, ATF2, C-MYC, miR-128, and GRP78 (Bip). Next, the anti-inflammatory and wound-healing properties of shikonin were also reviewed. Furthermore, several studies focusing on shikonin derivatives were reviewed, and these showed that, with modification to the naphthazarin ring or side chain, some shikonin derivatives display stronger anticancer activity and lower toxicity than shikonin itself. Our findings suggest that shikonin and its derivatives could serve as potential novel drug for the treatment of cancer and inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Zhang, F.-Y., Hu, Y., Que, Z., Wang, P., Liu, Y., Wang, Z., & Xue, Y. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161023823 · Cited by 94
RetractedHuang, C., & Hu, G. (2018) · Bioscience Reports · doi:10.1042/bsr20171546 · Cited by 49
RetractedModulation of oxidative stress as an anticancer strategy
Gorrini, C., Harris, I. S., & Mak, T. W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4002 · Cited by 3,579
Oxidative stress and cancer: An overview
Sosa, V., Moliné, T., Somoza, R., Paciucci, R., Kondoh, H., & LLeonart, M. E. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2012.10.004 · Cited by 1,439
Mitogen-activated protein kinases in apoptosis regulation
Wada, T., & Penninger, J. M. (2004) · Oncogene · doi:10.1038/sj.onc.1207556 · Cited by 1,432
Stine, Z. E., Walton, Z. E., Altman, B. J., Hsieh, A. L., & Dang, C. V. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0507 · Cited by 1,375
Li, J., McQuade, T., Siemer, A. B., Napetschnig, J., Moriwaki, K., Hsiao, Y.-S., Damko, E., Moquin, D., Walz, T., McDermott, A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.019 · Cited by 1,222
Compromised MAPK signaling in human diseases: an update
Kim, E. K., & Choi, E.-J. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1472-2 · Cited by 1,020
Broad targeting of resistance to apoptosis in cancer
Mohammad, R. M., Muqbil, I., Lowe, L., Yedjou, C., Hsu, H.-Y., Lin, L.-T., Siegelin, M. D., Fimognari, C., Kumar, N. B., Dou, Q. P., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.001 · Cited by 864
Progress in matrix metalloproteinase research
MURPHY, G., & NAGASE, H. (2008) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2008.05.002 · Cited by 759
An Overview of MYC and Its Interactome
Conacci-Sorrell, M., McFerrin, L., & Eisenman, R. N. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014357 · Cited by 408
Cellular pharmacology studies of shikonin derivatives
Chen, X., Yang, L., Oppenheim, J. J., & Howard, O. M. Z. (2002) · Phytotherapy Research · doi:10.1002/ptr.1100 · Cited by 401
Gut microbiota, a new frontier to understand traditional Chinese medicines
Feng, W., Ao, H., Peng, C., & Yan, D. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.02.024 · Cited by 377
Self-citationGonzalez-Avila, G., Sommer, B., Mendoza-Posada, D. A., Ramos, C., Garcia-Hernandez, A. A., & Falfan-Valencia, R. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.02.010 · Cited by 373
Oncogenic Roles of the PI3K/AKT/mTOR axis
Aoki, M., & Fujishita, T. (2017) · Current topics in microbiology and immunology · doi:10.1007/82_2017_6 · Cited by 355
The roles of nuclear focal adhesion kinase (FAK) on Cancer: a focused review
Zhou, J., Yi, Q., & Tang, L. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1265-1 · Cited by 287
Pharmacological Properties of Shikonin – A Review of Literature since 2002
Andújar, I., Ríos, J., Giner, R., & Recio, M. (2013) · Planta Medica · doi:10.1055/s-0033-1350934 · Cited by 282
The rheostat in the membrane: BCL-2 family proteins and apoptosis
Volkmann, N., Marassi, F. M., Newmeyer, D. D., & Hanein, D. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2013.153 · Cited by 224
Cai, J., Fang, L., Huang, Y., Li, R., Xu, X., Hu, Z., Zhang, L., Yang, Y., Zhu, X., Zhang, H., et al. (2017) · Nature Communications · doi:10.1038/ncomms15870 · Cited by 193
Thakur, R., Trivedi, R., Rastogi, N., Singh, M., & Mishra, D. P. (2015) · Scientific Reports · doi:10.1038/srep10194 · Cited by 183
Duan, D., Zhang, B., Yao, J., Liu, Y., & Fang, J. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.02.016 · Cited by 174
Emerging roles of the CXCL12/CXCR4 axis in pancreatic cancer progression and therapy
Sleightholm, R. L., Neilsen, B. K., Li, J., Steele, M. M., Singh, R. K., Hollingsworth, M. A., & Oupicky, D. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.05.012 · Cited by 171
Lu, L., Qin, A., Huang, H., Zhou, P., Zhang, C., Liu, N., Li, S., Wen, G., Zhang, C., Dong, W., et al. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.02.043 · Cited by 162
The role of ATF‐2 in oncogenesis
Vlahopoulos, S., Logotheti, S., Mikas, D., Giarika, A., Gorgoulis, V. G., & Zoumpourlis, V. C. (2008) · BioEssays · doi:10.1002/bies.20734 · Cited by 122
miR-128 and its target genes in tumorigenesis and metastasis
Li, M., Fu, W., Wo, L., Shu, X. H., Liu, F., & Li, C. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.07.031 · Cited by 111
Multifunctional molecule ERp57: From cancer to neurodegenerative diseases
Hettinghouse, A., Liu, R., & Liu, C.-J. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.07.011 · Cited by 110
Lin, T.-J., Lin, H.-T., Chang, W.-T., Pradeep Mitapalli., S., Hsiao, P., Yin, S., & Yang, N. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0435-9 · Cited by 105
Yang, J., Zhao, W., & Chen, D. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.06.086 · Cited by 104
Necroptosis promotes autophagy-dependent upregulation of DAMP and results in immunosurveillance
Lin, S., Hsieh, S., Fan, Y.-T., Wei, W., Hsiao, P., Tsai, D.-H., Wu, T., & Yang, N. (2017) · Autophagy · doi:10.1080/15548627.2017.1386359 · Cited by 98
Liu, Y., Kang, X., Niu, G., He, S., Zhang, T., Bai, Y., Li, Y., Hao, H., Chen, C., Shou, Z., et al. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1575229 · Cited by 96
Self-citationChen, Y., Zheng, L., Liu, J., Zhou, Z.-H., Cao, X., Lv, X., & Chen, F. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.05.026 · Cited by 90
An Oxidative Stress Mechanism of Shikonin in Human Glioma Cells
Yang, J., Li, Z.-L., Wu, J., Lu, F., & Chen, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094180 · Cited by 86
Wang, L., Li, Z., Zhang, X., Wang, S., Zhu, C., Miao, J., Chen, L., Cui, L., & Qiao, H. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1194-x · Cited by 85
Wada, N. A., Kawano, Y., Fujiwara, S., Kikukawa, Y., Okuno, Y., Tasaki, M., Ueda, M., ANDO, Y., Yoshinaga, K., Ri, M., et al. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2804 · Cited by 78
Andújar, I., Ríos, J. L., Giner, R. M., Cerdá, J. M., & Recio, M. C. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/271606 · Cited by 77
Shikonin inhibits myeloid differentiation protein 2 to prevent LPS‐induced acute lung injury
Zhang, Y., Xu, T., Pan, Z., Ge, X., Sun, C., Lu, C., Chen, H., Xiao, Z., Zhang, B., Dai, Y., et al. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14129 · Cited by 75
Sensitizing the Therapeutic Efficacy of Taxol with Shikonin in Human Breast Cancer Cells
Li, W., Liu, J., Jackson, K. L., Shi, R., & Zhao, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094079 · Cited by 73
Wang, Y., Zhou, Y., Jia, G., Han, B., Liu, J., Teng, Y., Lv, J., Song, Z., Li, Y., Ji, L., et al. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.041 · Cited by 73
Self-citationJang, S. Y., LEE, J. K., Jang, E. H., Jeong, S. Y., & Kim, J.-H. (2014) · Oncology Reports · doi:10.3892/or.2014.3159 · Cited by 72
Ahn, J., Won, M., Choi, J., Kim, Y. S., Jung, C.-R., Im, D., Kyun, M.-L., Lee, K., Song, K.-B., & Chung, K. (2013) · APOPTOSIS · doi:10.1007/s10495-013-0835-5 · Cited by 67
The Phytochemical Shikonin Stimulates Epithelial-Mesenchymal Transition (EMT) in Skin Wound Healing
Yin, S., Peng, A.-P., Huang, L., Wang, Y., Lan, C., & Yang, N. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/262796 · Cited by 65
Zhou, Z., Lu, B., Wang, C., Wang, Z., Luo, T., Piao, M., Meng, F., Chi, G., Luo, Y., & Ge, P. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.01.004 · Cited by 65
Fan, N., Huang, X., Chen, Z., Qian, W., & Tong, X. (2018) · Scientific Reports · doi:10.1038/s41598-018-21570-z · Cited by 63
Chen, Y. Z., Wang, T., Du, J., Li, Y., Wang, X., Zhou, Y., Yu, X., Fan, W., Zhu, Q., Tong, X., et al. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000490142 · Cited by 63
Self-citationLee, M.-J., Kao, S., Hunag, J.-E., Sheu, G., Yeh, C., Hseu, Y., Wang, C., & Hsu, L. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.01.008 · Cited by 62
Shikonin induces ROS-based mitochondria-mediated apoptosis in colon cancer
Liang, W., Cui, J., Zhang, K., Xi, H., Cai, A., Li, J., Gao, Y., Hu, C., Liu, Y., Lu, Y., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.22618 · Cited by 61
Huang, G., Zhao, H.-R., Meng, Q., Zhang, Q., Dong, J., Bao-quan, Z., & Li, S. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.11.031 · Cited by 56
Shikonin promotes intestinal wound healing in vitro via induction of TGF-β release in IEC-18 cells
Andújar, I., Rı́os, J. L., Giner, R. M., & Recio, M. C. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.05.018 · Cited by 55
Novel Multiple Apoptotic Mechanism of Shikonin in Human Glioma Cells
Chen, C., Lin, M.-L., Ong, P.-L., et al. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2324-4 · Cited by 53
Wang, H., Wu, C., Wan, S., Zhang, H., Zhou, S., & Liu, G. (2013) · Toxicology · doi:10.1016/j.tox.2013.03.015 · Cited by 48
Yeh, Y., Liu, T.-J., & Lai, H. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/620383 · Cited by 47
Tang, J., Zhao, J., Long, F., Chen, J., Mu, B., Jiang, Z., Ren, Y., & Yang, J. (2017) · Journal of Cancer · doi:10.7150/jca.21224 · Cited by 47
Shikonin Suppresses the Migratory Ability of Hepatocellular Carcinoma Cells
Wei, P., Tu, C.-C., Chen, C., Ho, Y., Wu, C., Su, H.-Y., Chen, W., Liu, J., & Chang, Y. (2013) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf4009586 · Cited by 43
Shikonin Inhibites Migration and Invasion of Thyroid Cancer Cells by Downregulating DNMT1
Zhang, Y., Sun, B., Huang, Z. L., Zhao, D., & Zeng, Q. (2018) · Medical Science Monitor · doi:10.12659/msm.908381 · Cited by 43
Wang, S., Zhu, Y., & Qiu, R. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.144 · Cited by 42
Kim, S.-J., Kim, J. M., Shim, S. H., & Chang, H. I. (2014) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.11.055 · Cited by 41
Li, M. Y., Mi, C., Wang, K. S., Wang, Z., Zuo, H. X., Piao, L. X., Xu, G. H., Li, X., Ma, J., & Jin, X. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.06.029 · Cited by 41
Shilnikova, K., Piao, M. J., Kang, K. A., Ryu, Y. S., Park, J., Hyun, Y., Zhen, A. X., Jeong, Y., Jung, U., Kim, I., et al. (2018) · Oncology Letters · doi:10.3892/ol.2018.8065 · Cited by 40
Senescence Inducer Shikonin ROS-Dependently Suppressed Lung Cancer Progression
Zheng, H., Huang, Q., Huang, S., Yang, X., Zhu, T., Wang, W., Wang, H., He, S., Ji, L., Wang, Y., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00519 · Cited by 40
Wang, X., Hayashi, S., Umezaki, M., Yamamoto, T., Kageyama‐Yahara, N., Kondo, T., & Kadowaki, M. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.10.021 · Cited by 39
Shikonin ameliorates cerulein-induced acute pancreatitis in mice
Xiong, J., Ni, J., Hu, G., Shen, J., Zhao, Y. F., Yang, L., Shen, J., Yin, G., Chen, C., Yu, G., et al. (2012) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2012.11.032 · Cited by 38
Piao, J., Cui, Z., Furusawa, Y., Ahmed, K., Rehman, M. U., Tabuchi, Y., Kadowaki, M., & Kondo, T. (2013) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2013.06.011 · Cited by 37
Trivedi, R., Muller, G. A., Rathore, M. S., Mishra, D. P., & Dihazi, H. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000445652 · Cited by 37
Shikonin Suppresses Skin Carcinogenesis via Inhibiting Cell Proliferation
Li, W., Zhang, C., Amy, R., Li, T., Jin, R., Li, G., Gu, X., Shi, R., & Zhao, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126459 · Cited by 35
Identification of New Shikonin Derivatives as Antitumor Agents Targeting STAT3 SH2 Domain
Qiu, H., Zhu, X., Luo, Y., Lin, H., Tang, C., Qi, J., Pang, Y.-J., Yang, R., Lu, G., Wang, X., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-02671-7 · Cited by 35
Investigating the potential of Shikonin as a novel hypertrophic scar treatment
Fan, C., Xie, Y., Dong, Y., Su, Y., & Upton, Z. (2015) · Journal of Biomedical Science · doi:10.1186/s12929-015-0172-9 · Cited by 34
Shan, Z., Zhong, L., Xiao, C.-L., Gan, L., Xu, T., Song, H., Yang, R., Li, L., & Liu, B. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6965 · Cited by 34
Ko, H., Kim, S.-J., Shim, S. H., Chang, H., & Ha, C. H. (2016) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2016.008 · Cited by 33
Lin, H., Li, Z.-K., Bai, L., Baloch, S. K., Wang, F., Qiu, H., Wang, X., Qi, J., Yang, R.-W., Wang, X., et al. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.04.021 · Cited by 31
Anti-inflammatory effects of shikonin in human periodontal ligament cells
Fan, C., Zhang, X., & Upton, Z. (2018) · Pharmaceutical Biology · doi:10.1080/13880209.2018.1506482 · Cited by 31
Li, B., Yuan, Z., Jiang, J. F., & Rao, Y. (2018) · Bioscience Reports · doi:10.1042/bsr20181693 · Cited by 30
Wiench, B., Chen, Y., Paulsen, M. S., Hamm, R., Schröder, S., Yang, N., & Efferth, T. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/818709 · Cited by 29
Shikonin sensitizes wild‑type EGFR NSCLC cells to erlotinib and gefitinib therapy
Li, Y.-L., Hu, X., Li, Q., Wang, F., Zhang, B., Ding, K., Tan, B., Lin, N., & Zhang, C. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9347 · Cited by 29
Self-citationShikonin induces an anti‑tumor effect on murine mammary cancer via p38‑dependent apoptosis
Xu, J., Koizumi, K., Liu, M., Mizuno, Y., Suzaki, M., Iitsuka, H., Inujima, A., Fujimoto, M., Shibahara, N., & Shimada, Y. (2019) · Oncology Reports · doi:10.3892/or.2019.6966 · Cited by 25
Prasad, R. G., Choi, Y. H., & Kim, G. (2015) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2015.006 · Cited by 17
Li, T., Yan, F., Wang, R., Zhou, H., & Liu, L. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/379536 · Cited by 17
Kazumura, K., Yoshida, L. S., Hara, A., Tsuchiya, H., Morishita, N., Kawagishi, H., Kakegawa, T., Yuda, Y., & Takano‐Ohmuro, H. (2016) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.16-4 · Cited by 11
Cited by
Iron Homeostasis and Ferroptosis in Human Diseases: Mechanisms and Therapeutic Prospects
Ru, Q., Li, Y., Chen, L., Wu, Y., Min, J., & Wang, F. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01969-z · Cited by 724
Self-citationAnticancer activities of TCM and their active components against tumor metastasis
Wang, K., Chen, Q., Shao, Y., Yin, S., Liu, C., Liu, Y., Wang, R., Wang, T., Qiu, Y., & Yu, H. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111044 · Cited by 381
Gao, Q., Feng, J., Liu, W., Wen, C., Wu, Y., Liao, Q., Zou, L., Sui, X., Xie, T., Zhang, J., et al. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114445 · Cited by 267
Pyruvate kinase M2 (PKM2) in cancer and cancer therapeutics
Zhu, S., Guo, Y., Zhang, X., Liu, H., Yin, M., Chen, X., & Peng, C. (2021) · Cancer Letters · doi:10.1016/j.canlet.2020.11.018 · Cited by 266
Self-citationThe macrophage polarization in inflammatory dermatosis and its potential drug candidates
Sun, Q., Hu, S., Lou, Z., & Gao, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114469 · Cited by 66
Metadata
- Authors
- Guo, C., He, J., Song, X., Tan, L., Wang, M., Jiang, P., Li, Y., Cao, Z., & Peng, C.
- Venue
- Pharmacological Research
- Publisher
- Elsevier BV
- Published
- 2019-11
- Volume
- 149
- Pages
- 104463
- ISSN
- 1043-6618 (ISSN-L)
- OpenAlex
- W2973628697
- Cited by
- 374
- References
- 77
- FWCI
- 55.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.